Effects of Different Inspiratory:Expiratory Ratios on Respiratory and Recovery Outcomes During Dental Procedures Under General Anesthesia in Pediatric Patients
A Clinical Study on the Effects of Different Inspiratory:Expiratory Ratios on Respiratory Function and Recovery in Pediatric Patients Undergoing Dental Procedures Under General Anesthesia
1 other identifier
observational
75
1 country
1
Brief Summary
This observational study aims to evaluate the effects of different inspiratory to expiratory (I:E) ratios (1:2 vs. 1:3) during mechanical ventilation in pediatric patients undergoing dental procedures under general anesthesia. Due to behavioral challenges, dental phobia, or medical conditions, general anesthesia is often required to ensure immobility and cooperation during dental treatments in children. In the clinic where the study will be conducted, the I:E ratio is routinely adjusted approximately 20-30 minutes before the end of the procedure to facilitate a smoother transition to spontaneous breathing during emergence from anesthesia. While 1:2 is commonly used, the 1:3 ratio may improve respiratory efficiency and recovery by prolonging the expiratory phase. The study aims to compare vital signs, respiratory parameters (heart rate, blood pressure, SpO₂, EtCO₂, respiratory rate), recovery quality, and respiratory complications between the two I:E ratios. The findings aim to optimize ventilation strategies and improve patient comfort and safety during emergence from anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
April 9, 2026
April 1, 2026
8 months
November 14, 2025
April 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Post-Extubation Respiratory Quality
Respiratory quality will be assessed using a study-specific observational scale (range 0-10; higher scores indicate poorer respiratory quality). Components include spontaneous breathing adequacy, accessory muscle use, airway patency, response to painful stimuli, and coughing episodes.
During 10 minutes after extubation
Respiratory Rate (RR)
Mean respiratory rate (breaths/min) recorded during spontaneous breathing while EtCO₂ is maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).
During the emergence preparation period (approximately 25-35 minutes prior to extubation, up to 40 minutes if required)
Peak Airway Pressure (PeakP)
Peak airway pressure (cmH₂O) recorded during emergence preparation period for each I:E ratio group (1:2 vs. 1:3).
During the emergence preparation period (approximately 25-35 minutes prior to extubation, up to 40 minutes if required)
Heart Rate
Mean heart rate (beats/min) recorded during spontaneous breathing while EtCO₂ and sevoflurane MAC are maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).
During the emergence preparation period (approximately 20-30 minutes prior to extubation, up to 40 minutes if required)
Blood Pressure
Mean arterial blood pressure (mmHg) recorded during spontaneous breathing while EtCO₂ and sevoflurane MAC are maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).
During the emergence preparation period (approximately 20-30 minutes prior to extubation, up to 40 minutes if required)
Secondary Outcomes (6)
Physical Response During Extubation
From 2 minutes before extubation to 2 minutes after extubation
Occurrence of Bronchospasm or Laryngospasm
From extubation until 30 minutes after extubation
Preoperative Anxiety Level Assessed by the Modified Yale Preoperative Anxiety Scale (mYPAS)
Immediately before surgery (prior to operating room entry)
Pediatric Anesthesia Emergence Delirium (PAED) Score
From emergence from anesthesia through recovery unit stay until discharge, assessed up to 1 hour
Modified Aldrete Score
From emergence from anesthesia through recovery unit stay until discharge, assessed up to 1 hour
- +1 more secondary outcomes
Study Arms (3)
Group 1: Control
Patients who emerge from anesthesia earlier than planned without pre-emergence preparation. A minimum of 15 patients will be enrolled in this group.
Group 2: I:E 1:2
Patients undergoing standart dental procedures under general anesthesia; during the last phase of the procedure, mechanical ventilation will be applied with an I:E ratio of 1:2. A minimum of 30 patients will be enrolled in this group.
Group 3: I:E 1:3
Patients undergoing standart dental procedures under general anesthesia; during the last phase of the procedure, mechanical ventilation will be applied with an I:E ratio of 1:3. A minimum of 30 patients will be enrolled in this group.
Eligibility Criteria
The study will include pediatric patients aged 2 to 12 years who are scheduled to undergo routine dental procedures under general anesthesia at our faculty. Eligible participants are classified as American Society of Anesthesiologists (ASA) Physical Status I or II. Patients with airway anomalies, significant adenoid hypertrophy, macroglossia, retrognathia, severe obesity, developmental delays, or a history of delayed emergence from anesthesia will be excluded. Children requiring anesthesia for less than 1 hour or more than 3 hours, those with known pulmonary or airway diseases, neuromuscular disorders affecting respiration, or receiving medications that could alter spontaneous breathing during emergence (e.g., atropine, lidocaine, steroids) are also excluded. Written informed consent must be obtained from parents or legal guardians prior to participation.
You may qualify if:
- Pediatric patients scheduled for dental procedures under general anesthesia at our faculty.
- American Society of Anesthesiologists (ASA) Physical Status I or II.
- Age between 2 and 12 years.
- Written informed consent obtained from parents or legal guardians.
You may not qualify if:
- Patients whose parents or legal guardians decline participation.
- Presence of adenoid hypertrophy \>30%.
- Macroglossia or retrognathia.
- Severe obesity or developmental delay.
- History of delayed emergence from anesthesia.
- ASA Physical Status III or higher.
- Anesthesia duration less than 1 hour or more than 3 hours.
- Patients with difficult airway management or ventilation.
- Known pulmonary or airway diseases or anomalies.
- Use of pharmacological agents that may affect spontaneous respiratory quality.
- Presence of neuromuscular disorders affecting respiratory function.
- Age \<2 years or \>12 years.
- Administration of medications intraoperatively or preoperatively that may influence respiratory dynamics during emergence (e.g., atropine, lidocaine, steroids).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kırıkkale University, Faculty of Dentistry
Kırıkkale, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 14, 2025
First Posted
January 7, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared; however, the dataset will be made available upon reasonable request to the corresponding author, subject to approval and relevant ethical considerations.